Jean Park

Partner
jpark@cooley.com
Full contact info

I am passionate about providing excellent legal advice in a pragmatic and thoughtful way.

About Jean

Jean advises companies, investors and investment banks on a broad range of transactional and general corporate matters, including IPOs and other securities offerings, private investment in public equity (PIPE) transactions, private financings, and mergers and acquisitions. She also counsels late-stage private companies and public companies on the full spectrum of general corporate and securities laws matters.

View full bio

Experience

ProfoundBio Announces $1.8 Billion Acquisition by Genmab

ProfoundBio Announces $1.8 Billion Acquisition by Genmab

April 3, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its definitive agreement to be acquired for $1.8 billion in an all-cash transaction by Genmab (NASDAQ: GMAB), a dual-listed, international biotechnology company that creates and develops differentiated antibody therapeutics to fight against cancer and other serious diseases.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Rowook Park
Partner, San Diego
Ruomu Li
Partner, Shanghai
Jenny Ge
Associate, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica
Jamie Leigh
Partner, San Francisco
Izzy Lubarsky
Partner, New York
Barbara Mirza
Partner, Los Angeles Santa Monica
Sonia Nath
Partner, Washington, DC
Jean Park
Partner, New York
Lei Shen
Partner, Chicago
Elizabeth Anne Wright
Of Counsel, Brussels
Stacey A. Bradford
Special Counsel, Washington, DC
Jeff Goldman
Special Counsel, Palo Alto
Amy Hallman Rice
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Andrew Bae
Associate, Washington, DC
Julia R. Brinton
Associate, Washington, DC
Megan Drill
Associate, San Diego
Mari Dugas
Associate, Washington, DC
Allison Kutner
Associate, New York
Joyce Li
Associate, Chicago
Jiqiang Lin
Associate, New York
Tyler McClure
Associate, San Francisco
Patrick Sharma
Associate, Los Angeles Santa Monica
Ivy Wang
Associate, Shanghai
Monica Xu
Counsel, Shanghai
Freddy Yip
Associate, Hong Kong
Zhijing Yu
Associate, Singapore
Andy Zachrich
Associate, San Diego
Letian Wei
Legal Consultant, Shanghai
Sherlyn Qu
Legal Consultant, Shanghai

Related Practices & Industries

Mergers and Acquisitions
Biotechnology
Healthcare
Life Sciences
Life Sciences and Healthcare Regulatory
Life Sciences Corporate Partnering and Licensing
Asia
Emerging Companies
Tax
Cyber/Data/Privacy
Compensation and Benefits
Labor and Employment
Antitrust and Competition
CFIUS

Definitive Healthcare Acquires Populi

Definitive Healthcare Acquires Populi

August 14, 2023

Cooley advised Definitive Healthcare, a commercial intelligence company focused on healthcare, on its acquisition of Populi.

Read more

Related contacts

Alfred Browne
Partner, Boston
Miguel J. Vega
Partner, Boston
Heather Harrington
Special Counsel, Boston
Thomas Connors
Partner, Boston
Todd Gluth
Partner, San Diego
Phil Mitchell
Partner, New York
Nyron J. Persaud
Partner, New York
Jean Park
Partner, New York
David Navetta
Partner, Colorado
Jennifer Shanley
Special Counsel, New York
Ryan Montgomery
Special Counsel, Boston
Kristopher Kleiner
Special Counsel, Colorado
Ariane A. Andrade
Partner, Chicago
Shari Ness
Special Counsel, New York
Bronwyn L. Roberts
Special Counsel, Boston
Stacey A. Bradford
Special Counsel, Washington, DC
Mary Maher Lewis
Special Counsel, Reston
Etenish Abebe
Associate, Boston
Nick Kenyon
Associate, Boston
Erica Pedersen
Associate, Boston
Patrick O. Johnson
Associate, Boston
Joe Mandry
Associate, San Diego
Jimmy Gilligan
Associate, Boston
Allison Kutner
Associate, New York
Wyatt Kernell
Associate, New York
Cara Buchicchio
Associate, New York
Rachel F. Katz
Associate, New York
Michael Gladstone
Associate, New York
Erica Russell
Associate, San Francisco
Charlotte Yin
Associate, New York
Julia Boesch
Partner, San Francisco
Mara Rosario
Associate, Boston
Sydney Sachs
Associate, Boston
Liza Cotter
Associate, Boston
Elizabeth Rice
Paralegal Specialist, Boston
Jill Simon
Senior Paralegal, New York
Megan Boss
Senior Paralegal , Boston

Related Practices & Industries

Mergers and Acquisitions
Private Equity
Healthcare
Technology Transactions
Tax
Compensation and Benefits

NewAmsterdam Pharma – $181.6 Million Follow-on Offering

NewAmsterdam Pharma – $181.6 Million Follow-on Offering

June 6, 2023

Cooley advised the underwriters in NewAmsterdam Pharma’s $181.6 million follow-on offering. NewAmsterdam is a clinical-stage biopharmaceutical company with a mission to improve care of patients with metabolic diseases where currently approved therapies have not been sufficiently successful or well tolerated. Lawyers Eric Blanchard, Div Gupta, Jean Park, Minkyu Park, Charles York, and Katie Lapidus led the Cooley team.

Related contacts

Eric Blanchard
Partner, Boston
Div Gupta
Partner, New York
Jean Park
Partner, New York
Minkyu Park
Associate, New York
Charles York
Associate, New York
Katie Lapidus
Associate, Washington, DC

Related Practices & Industries

Capital Markets
Life Sciences

Karuna Therapeutics – $460 Million Follow-on Offering

Karuna Therapeutics – $460 Million Follow-on Offering

March 21, 2023

Cooley advised the underwriters in Karuna Therapeutics’ $460 million follow-on offering. Karuna is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Goldman Sachs & Co., JP Morgan, Morgan Stanley, Stifel, and Guggenheim Securities acted as joint book-running managers for the offering. Partners Richard Segal, Div Gupta and Jean Park led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Jean Park
Partner, New York
Darah Protas
Partner, Washington, DC
Katie Lapidus
Associate, Washington, DC
Quay Strozier
Associate, Washington, DC
Charles York
Associate, New York

Related Practices & Industries

Capital Markets
Life Sciences

Karuna Therapeutics – $862.5 Million Follow-on Offering

Karuna Therapeutics – $862.5 Million Follow-on Offering

September 7, 2022

Cooley advised the underwriters in Karuna Therapeutics’ $862.5 million follow-on offering of 4,011,628 shares of common stock at a public offering price of $215 per share. Karuna is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Partners Richard Segal, Jean Park, Div Gupta and associate Darah Protas led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Jean Park
Partner, New York
Div Gupta
Partner, New York
Darah Protas
Partner, Washington, DC
Charles York
Associate, New York
Katie Lapidus
Associate, Washington, DC
Quay Strozier
Associate, Washington, DC
Katherine King
Associate, Washington, DC

Related Practices & Industries

Capital Markets
Life Sciences
Healthcare
View more

Admissions & credentials

New York

California

Rankings & accolades

The Deal: Top Rising Star (2021)